Cat. #161950
VCaP 1 [source] Cell line
Cat. #: 161950
Availability: 8-10 weeks
Organism: Human
Tissue: Prostate
Disease: Cancer
Model: Tumour Cell Line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Wytske van Weerden
Institute: Erasmus University Medical Centre
Primary Citation: Moll JM et al. 2022. Front. Oncol. Jun 13,12:877613. PMID: 35769712
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: VCaP 1 [source] Cell line
- Research fields: Cancer
- Organism: Human
- Tissue: Prostate
- Disease: Cancer
- Model: Tumour Cell Line
- Receptors of note: Androgen receptor
- Description: CRPC VCaP cell line series - source. VCaP is a human prostate cancer cell line that expresses wild-type androgen receptor (AR), this cell line has been used as a model to study AR signalling in prostate cancer. This cell line is the source cell line from which a series of VCaP CRPC models were generated, by long-term passaging cells in androgen depleted media and with antiandrogens.
- Application: Tumour Modelling
Applications
- Application: Tumour Modelling
Handling
- Growth medium: RPMI1640 + 10% FCS
- Storage conditions: liquid N2
- Cultured in antibiotics: 1% Penicillin/Streptomycin
References
- Moll JM et al. 2022. Front. Oncol. Jun 13,12:877613. PMID: 35769713
